Predicted to enable signaling receptor activity. Predicted to be involved in positive regulation of lymphocyte activation. Predicted to act upstream of or within B cell homeostasis; positive regulation of germinal center formation; and positive regulation of type II interferon production. Predicted to be active in external side of plasma membrane. Human ortholog(s) of this gene implicated in common variable immunodeficiency 4. Orthologous to human TNFRSF13C (TNF receptor superfamily member 13C); PARTICIPATES IN cytokine mediated signaling pathway; primary immunodeficiency pathway; INTERACTS WITH 1,2-dimethylhydrazine; 17beta-estradiol; alpha-Zearalanol.
LOC500910; RGD1560810; similar to tumor necrosis factor receptor superfamily, member 13c; tumor necrosis factor receptor superfamily member 13C; tumor necrosis factor receptor superfamily, member 13c
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA